There were 320 press releases posted in the last 24 hours and 440,402 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image